BSF Enterprise PLC BSFA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX1.13
- Day Range
- GBX1.06–1.25
- 52-Week Range
- GBX0.50–42.00
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 203.85M
- Market Cap
- GBX229.33M
- Volume/Avg
- 953,314 / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 28.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 4
- Website
- https://www.bsfenterprise.com
Valuation
|
Metric
|
BSFA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.85 |
Price/Sales | 28.20 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BSFA
|
|---|---|
Quick Ratio | 0.31 |
Current Ratio | 0.42 |
Interest Coverage | −190.12 |
Quick Ratio
BSFA
Profitability
|
Metric
|
BSFA
|
|---|---|
Return on Assets (Normalized) | −39.26% |
Return on Equity (Normalized) | −52.65% |
Return on Invested Capital (Normalized) | −46.12% |
Return on Assets
BSFA
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|D%?B%^ | LOCK|w$Wd | $128B | |||
| Moderna Inc
MRNA
| LOCK|q#&$kH | LOCK|$j! | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|YSx!@< | LOCK|?Q>F | $76B | |||
| argenx SE ADR
ARGX
| LOCK|CXc@YN | LOCK|Qq | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>FT?NrB | LOCK|<z | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|%PJBSN | LOCK|FG$>X | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|p>?nKF@ | LOCK|&N!% | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|#FC%Lp^ | LOCK|!Y | $24B | |||
| Incyte Corp
INCY
| LOCK|!?jc!@ | LOCK|C! | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|#PdnZ@? | LOCK|hG | $15B |
United States